JP2005510201A5 - - Google Patents

Download PDF

Info

Publication number
JP2005510201A5
JP2005510201A5 JP2002559456A JP2002559456A JP2005510201A5 JP 2005510201 A5 JP2005510201 A5 JP 2005510201A5 JP 2002559456 A JP2002559456 A JP 2002559456A JP 2002559456 A JP2002559456 A JP 2002559456A JP 2005510201 A5 JP2005510201 A5 JP 2005510201A5
Authority
JP
Japan
Prior art keywords
antibody
antigen
binding portion
atcc accession
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002559456A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005510201A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/002171 external-priority patent/WO2002059154A2/en
Publication of JP2005510201A publication Critical patent/JP2005510201A/ja
Publication of JP2005510201A5 publication Critical patent/JP2005510201A5/ja
Pending legal-status Critical Current

Links

JP2002559456A 2001-01-26 2002-01-25 Ｈｉｖ−１に対する中和ヒトモノクローナル抗体、それらの産生および使用 Pending JP2005510201A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26439801P 2001-01-26 2001-01-26
US26610601P 2001-02-02 2001-02-02
US26598401P 2001-02-03 2001-02-03
US27046601P 2001-02-21 2001-02-21
PCT/US2002/002171 WO2002059154A2 (en) 2001-01-26 2002-01-25 Neutralizing human monoclonal antibodies against hiv-1, their production and uses

Publications (2)

Publication Number Publication Date
JP2005510201A JP2005510201A (ja) 2005-04-21
JP2005510201A5 true JP2005510201A5 (enExample) 2005-12-22

Family

ID=27500822

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002559456A Pending JP2005510201A (ja) 2001-01-26 2002-01-25 Ｈｉｖ−１に対する中和ヒトモノクローナル抗体、それらの産生および使用

Country Status (5)

Country Link
US (1) US20050058983A1 (enExample)
EP (1) EP1373318A2 (enExample)
JP (1) JP2005510201A (enExample)
CA (1) CA2436091A1 (enExample)
WO (1) WO2002059154A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1537139A2 (en) * 2002-09-13 2005-06-08 Creabilis Therapeutics S.P.A. A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism
EP1431306A1 (en) * 2002-12-19 2004-06-23 Creabilis Therapeutics s.r.l. A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism
US6821744B2 (en) * 2002-10-29 2004-11-23 Roche Diagnostics Operations, Inc. Method, assay, and kit for quantifying HIV protease inhibitors
BR0316245A (pt) * 2002-11-14 2005-10-04 Novartis Ag Atividade antimicrobiana de espécie de oxigênio reativo produtora de anticorpos
US8332159B2 (en) 2003-02-20 2012-12-11 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Method for enhancing efficacy of preparation of monoclonal antibody
FR2861255B1 (fr) 2003-10-24 2006-02-17 Centre Nat Rech Scient Mammifere non-humain transgenique pour la region constante de la chaine lourde des immunoglobulines humaines de classe a et ses applications.
US20060205070A1 (en) * 2004-01-13 2006-09-14 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services HIV TEV compositions and methods of use
JP2008504531A (ja) * 2004-06-24 2008-02-14 ザ スクリップス リサーチ インスティテュート 切断可能なリンカーを有するアレイ
WO2010096042A1 (en) 2008-10-30 2010-08-26 Dana-Farber Cancer Institute Mimotopes of hiv env
WO2014052620A1 (en) * 2012-09-26 2014-04-03 Duke University Adcc-mediating antibodies, combinations and uses thereof
PT2908912T (pt) 2012-10-18 2020-09-04 Univ Rockefeller Anticorpos anti-hiv amplamente neutralizantes
US9101597B2 (en) 2013-03-14 2015-08-11 The Administration Of The Tulane Educational Fund Immunoprotective primary mesenchymal stem cells and methods
CN107936116A (zh) * 2018-01-16 2018-04-20 河南牧业经济学院 高效价抗csfv单克隆抗体的制备方法
CN113813375B (zh) * 2020-06-19 2023-06-16 杭州星鳌生物科技有限公司 一种新型抗新冠病毒复合物的组成及其在防治冠状病毒感染疾病药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266478A (en) * 1987-05-29 1993-11-30 Tanox Biosystems, Inc. Antibodies which target a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120
US5643756A (en) * 1992-08-28 1997-07-01 The Public Health Research Institute Of The City Of New York, Inc. Fusion glycoproteins
AU2119695A (en) * 1994-03-16 1995-10-03 Tanox Biosystems, Inc. Synergistic inhibition of hiv-1 infection using a nucleoside reverse transcriptase inhibitor and anti-hiv-1 antibodies
WO1996034096A1 (en) * 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6815201B2 (en) * 1997-09-08 2004-11-09 The Public Health Research Institute Of The City Of New York, Inc. HIV-1 gp120 V1/V2 domain epitopes capable of generating neutralizing antibodies

Similar Documents

Publication Publication Date Title
CN110799539B (zh) 抗4-1bb抗体及其制备和使用方法
JP7640466B2 (ja) Ｃｄ４０活性化特性を有する組換えタンパク質
US8513391B2 (en) Monoclonal antibodies for Ebola and Marburg viruses
US20260062493A1 (en) Antibody Targeting BCMA, Bispecific Antibody, And Use Thereof
JP2012518425A5 (enExample)
WO2018113258A1 (zh) 抗pd-1抗体及其用途
CA2980751A1 (en) Multi-valent hepatitis b virus antigen binding molecules and uses thereof
JP2019528050A (ja) 抗ジカ（ｚｉｋａ）ウイルス抗体およびその使用方法
RU2004127458A (ru) Анти-cd20 антитела, их гибридные белки и способы их использования
CA2487060A1 (en) Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
RU2011101969A (ru) Антитела к человеческому интерлейкину-20
US20210253713A1 (en) Antibodies targeting a complex comprising non-classical hla-i and neoantigen and their methods of use
TWI906795B (zh) 特異性結合Ｃｌａｕｄｉｎ １８.２的抗體及其製法和應用
WO2025246679A1 (zh) 一种广谱中和冠状病毒的抗体及其应用
WO2022150740A1 (en) Cross-reactive antibodies recognizing the coronavirus spike s2 domain
JP2022536913A (ja) Ｐｄ－１に対する抗体およびその使用方法
AU2002243259B2 (en) Monoclonal antibodies specific for the E2 glycoprotein of hepatitis C virus and their use in the diagnosis, treatment, and prevention of hepatitis C
US7625566B2 (en) Anti-idiotypic monoclonal antibody reactive with HIV neutralizing antibody 2F5
IL277899B1 (en) Methods and compositions for treating yellow fever
TWI910636B (zh) 特異性結合cll1的抗體及其製法和應用
WO2023071953A1 (zh) 抗cd26抗体及其应用
US20210115113A1 (en) Epstein-barr virus antibodies and uses thereof
RU2817696C1 (ru) Моноклональное антитело iC1 и его антигенсвязывающий фрагмент, селективно связывающие рецептор-связывающий домен Spike-белка вируса SARS-CoV-2, обладающие вируснейтрализующей активностью
CN116041492B (zh) 一种抗rbd抗体及其应用
RU2817697C1 (ru) Моноклональное антитело iC2 и его антигенсвязывающий фрагмент, селективно связывающие рецептор-связывающий домен Spike-белка вируса SARS-CoV-2, обладающие вируснейтрализующей активностью